NCT02592356 2024-03-05Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerM.D. Anderson Cancer CenterPhase NA Completed23 enrolled